Status:
ACTIVE_NOT_RECRUITING
Contingency Management for Opioid and Stimulant Use Disorders in Primary Care
Lead Sponsor:
University of Minnesota
Conditions:
Opioid Use Disorder
Stimulant Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Contingency management (CM) is a behavioral intervention that involves incentivizing participants for target behaviors in a clinical setting. When applied to the treatment of substance use disorders, ...
Eligibility Criteria
Inclusion
- At least 18 years of age
- Diagnosis of Opioid Use Disorder and/or Stimulant Use Disorder
- Recently initiated medications for opioid use disorder (MOUDs) at Broadway Family Medicine (BFM), within 2 weeks of recruitment
- Have an active prescription for buprenorphine-naloxone (Suboxone)
Exclusion
- Prescription for an amphetamine would exclude patients from the abstinence-based CM, but they could participate in the attendance-only CM.
- Dementia, development disabilities, or cognitive functioning that is too low to participate in study measures, as determined by chart review and consultation with overseeing physician.
Key Trial Info
Start Date :
June 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2026
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT05288751
Start Date
June 15 2022
End Date
August 31 2026
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455